Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagayama, K
Right arrow Articles by Sato, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagayama, K
Right arrow Articles by Sato, C
Gut 2001;48:830-835 ( June )

Article

Sequences in the NS5A protein of hepatitis C virus and the serum alanine aminotransferase response to interferon therapy in Japanese patients K Nagayamaa, N Enomotoa, N Izumib, M Kurosakia, Y Miyasakaa, H Watanabea, J Itakuraa, C-H Chena, J Tazawac, Y Hoshinod, T Ikedad, F Marumoa, C Satoe

a Second Department of Internal Medicine, Faculty of Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan, 113-8519, b Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, 1-26-1 Kyonan-cho, Musashino city, Tokyo, Japan, 180-8610, c Department of Internal Medicine, Tsuchiura Kyodo General Hospital, 14-7 Manabe-shinmachi, Tsuchiura city, Ibaraki, Japan, 300-0053, d Second Department of Internal Medicine, Yokosuka Kyosai General Hospital, 22-7 Yonegahama-dori, Yokosuka city, Kanagawa, Japan, 238-0011, e Department of Health Science, Faculty of Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan, 113-8519

Correspondence to: Dr N Enomoto. nenomoto.med2{at}med.tmd.ac.jp

Accepted for publication 12 December 2000

BACKGROUND AND AIMS---Chronic hepatitis C is a slowly progressive disease and eventually causes hepatocellular carcinoma in many patients. Although interferon (IFN) therapy has been used for viral eradication, its success rate is only about 30%. In patients in whom it has failed (non-responders), there are several patterns of serum alanine aminotransferase (ALT) values, and detection of serum HCV-RNA during and after IFN therapy and improved long term prognosis were reported in patients whose serum ALT values were normalised by IFN therapy even if HCV viraemia persisted. The present study sought to clarify the virological characteristics contributing to these differences.
METHODS---Complete or partial length dominant sequences of hepatitis C virus genotype 1b (HCV-1b) were determined by direct sequencing. Firstly, the complete sequences of HCV-1b genomes were determined in six non-responders; three showed normalisation of serum ALT values during IFN-alpha therapy and the other three did not. Subsequently, the amino acid residues that were different in the two groups were further analysed retrospectively in another 82 patients.
RESULTS---Comparison of the sequences suggested an association between amino acids 2154-2172 of HCV-1b and serum ALT normalisation. A retrospective analysis of 82 patients revealed that the number of amino acid substitutions in this region was the only statistically significant variable associated with ALT normalisation (odds ratio 31.0; 95% confidence interval 5.0-286) in multivariate analyses.
CONCLUSIONS---A HCV genomic region that correlates with the ALT response to IFN therapy appears to be present in virologically IFN ineffective patients.


Keywords: hepatitis C virus; alanine aminotransferase; biochemical responder; transient responder; NS5A protein

© 2001 by Gut




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2001 BMJ Publishing Group Ltd & British Society of Gastroenterology